The SQSTM1 Gene Paget Disease of Bone Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the SQSTM1 gene, which are closely associated with Paget's disease of bone. Paget's disease is a chronic disorder that can lead to enlarged and misshapen bones in adults, often leading to bone pain, arthritis, deformities, and fractures. The SQSTM1 gene plays a critical role in bone remodeling and maintenance, and mutations in this gene are found in a significant proportion of patients with familial or sporadic forms of Paget's disease.
This genetic test involves collecting a DNA sample, usually through a blood draw, and analyzing it for specific mutations in the SQSTM1 gene. Identifying these mutations can help in confirming a diagnosis of Paget's disease, especially in patients who present with typical symptoms or have a family history of the disease. It can also aid in the early detection of the disease, allowing for timely management and treatment strategies to prevent complications.
The cost of the SQSTM1 Gene Paget Disease of Bone Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity and the specialized nature of this genetic test, it represents a critical step towards personalized medicine for patients with or at risk of developing Paget's disease. This test is an essential tool for healthcare providers in the diagnosis, treatment planning, and management of patients affected by this condition.
The TNFRSF11B gene plays a critical role in bone remodeling and density regulation. Mutations in this gene are associated with juvenile Paget's disease, a rare bone disorder characterized by rapid bone growth and remodeling that can lead to skeletal deformities, pain, and fractures. The genetic test for juvenile Paget's disease focuses on identifying mutations in the TNFRSF11B gene to confirm a diagnosis, allowing for early intervention and management of the condition.
Conducted at DNA Labs UAE, this specialized genetic test is priced at 4400 AED. By analyzing a sample of the patient's DNA, the test can detect specific mutations in the TNFRSF11B gene that are indicative of juvenile Paget's disease. The results of this test not only aid in confirming a diagnosis but also help in understanding the disease's progression, guiding treatment options, and providing crucial information for family planning.
The KRT16 gene palmoplantar keratoderma nonepidermolytic focal genetic test is a specialized diagnostic procedure aimed at identifying mutations in the KRT16 gene, which are known to cause a specific form of palmoplantar keratoderma (PPK). This non-epidermolytic, focal type of PPK is a rare genetic skin disorder characterized by the development of thick, callus-like areas on the palms of the hands and soles of the feet. These skin abnormalities are due to excessive growth of the keratin layer in the epidermis, directly linked to mutations in the KRT16 gene.
Conducted at DNA Labs UAE, this genetic test is crucial for accurate diagnosis, enabling targeted management and genetic counseling for affected individuals and their families. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the KRT16 gene that are associated with the condition.
The cost of the KRT16 gene palmoplantar keratoderma nonepidermolytic focal genetic test is 4400 AED. This investment covers the comprehensive analysis required to detect the presence of the genetic mutation, offering invaluable insights for the management of the condition. It is a pivotal step towards personalized treatment planning, helping to mitigate symptoms and improve the quality of life for those affected by this rare genetic disorder.
The CTSC Gene Papillon-Lefevre Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CTSC gene, which are responsible for causing Papillon-Lefevre Syndrome (PLS). PLS is a rare genetic disorder characterized by severe periodontitis leading to early loss of teeth and palmoplantar keratoderma, a condition that causes the skin on the palms of the hands and soles of the feet to become thick, scaly, and cracked. The test is crucial for early detection, allowing for timely intervention and management of the syndrome's symptoms. Conducted through a simple and non-invasive process, it offers a definitive analysis for those suspected of having the condition or carriers of the gene mutation looking to understand their genetic health better. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and expert consultation provided by DNA Labs UAE, ensuring clients receive accurate and actionable insights into their genetic predisposition towards Papillon-Lefevre Syndrome.
The "CDSN Gene Peeling Skin Syndrome Type 1 Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, aimed at identifying mutations in the CDSN gene, which are linked to Peeling Skin Syndrome Type 1. This rare genetic disorder is characterized by chronic, spontaneous skin peeling due to a deficiency in the corneodesmosin protein, crucial for skin cell adhesion. The test plays a vital role in confirming the diagnosis, enabling personalized management plans, and providing essential information for family planning. Conducted with precision and confidentiality, the test costs 4400 AED and represents a significant step forward in the field of genetic diagnostics, offering hope and clarity to affected individuals and their families.
The GNAS Gene Osseous Heteroplasia Progressive Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the GNAS gene, which are associated with Progressive Osseous Heteroplasia (POH). POH is a rare genetic disorder characterized by the formation of bone in tissues where bone normally does not exist, such as skin and muscle. This condition can lead to severe physical limitations and discomfort for affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test offers individuals and families the opportunity to understand the genetic basis of POH, allowing for early diagnosis and the possibility of managing the condition more effectively. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the GNAS gene that are known to cause the disorder.
The cost of the GNAS Gene Osseous Heteroplasia Progressive Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem high, the test provides invaluable information that can guide medical treatment and interventions, potentially improving the quality of life for those affected by POH. Early detection and understanding of the genetic underpinnings of the condition are crucial steps in managing symptoms and preventing complications.
The "COL2A1 Gene Osteoarthritis with Mild Chondrodysplasia Genetic Test" is a specialized diagnostic tool offered at DNA Labs UAE, designed to identify mutations in the COL2A1 gene. This gene plays a crucial role in the production of type II collagen, a major component of cartilage tissue. Mutations in the COL2A1 gene are associated with various skeletal disorders, including osteoarthritis and mild chondrodysplasia, conditions characterized by joint pain and cartilage abnormalities, respectively.
Osteoarthritis is a common degenerative joint disease that leads to the breakdown of joint cartilage and underlying bone, causing pain and stiffness, primarily in the hands, knees, hips, and spine. On the other hand, chondrodysplasia refers to a group of disorders characterized by the abnormal development of cartilage and bone, leading to skeletal and growth abnormalities.
The test available at DNA Labs UAE aims to provide individuals with precise genetic information regarding the COL2A1 gene, enabling early detection and the possibility of personalized management strategies for those affected by or at risk of developing these conditions. This proactive approach can significantly impact the quality of life of individuals with a predisposition to osteoarthritis and chondrodysplasia by allowing for early interventions.
Priced at 4400 AED, the test is conducted in a state-of-the-art facility equipped with the latest in genetic testing technology, ensuring accurate and reliable results. DNA Labs UAE is committed to providing comprehensive support and guidance throughout the testing process, from sample collection to result interpretation, helping individuals understand their genetic health and take informed steps towards managing their condition.
The CSF1 gene plays a crucial role in osteogenesis, the process of bone formation, and has been implicated in various dental anomalies. Mutations or alterations in the CSF1 gene can lead to a range of bone and dental issues, impacting both the structure and health of bones and teeth. Understanding the genetic underpinnings of these conditions is essential for accurate diagnosis and effective treatment.
DNA Labs UAE offers a specialized genetic test targeting the CSF1 gene to identify mutations that may contribute to osteogenesis irregularities and dental anomalies. This test is a valuable tool for healthcare professionals in diagnosing and managing related conditions, enabling personalized treatment plans based on genetic insights.
The test cost is set at 4400 AED, reflecting the comprehensive analysis and detailed report provided. Conducted in a state-of-the-art facility, DNA Labs UAE ensures accuracy and reliability in results, making it a trusted choice for patients and clinicians alike seeking insights into CSF1 related conditions.
The CREB3L1 gene plays a crucial role in the regulation of osteogenesis, the process by which bone is formed. Mutations or alterations in the CREB3L1 gene can lead to disorders affecting bone development and strength, causing a range of skeletal abnormalities. Recognizing the importance of accurate diagnosis for individuals suspected of having CREB3L1-related osteogenesis disorders, DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the CREB3L1 gene.
This genetic test is a critical tool for healthcare professionals in diagnosing conditions linked to the CREB3L1 gene, enabling the implementation of appropriate treatment plans and genetic counseling for affected individuals and their families. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the CREB3L1 gene.
DNA Labs UAE, known for its commitment to providing high-quality diagnostic services, conducts this test with precision and accuracy. The cost of the CREB3L1-related genetic test is 4400 AED, reflecting the sophisticated technology and expertise required to perform this analysis. By offering this test, DNA Labs UAE supports the early detection and management of osteogenesis disorders, contributing to improved patient outcomes and quality of life for those affected by conditions related to the CREB3L1 gene.
The COL1A1 gene osteogenesis imperfecta genetic test is a specialized diagnostic tool used for the detection of mutations in the COL1A1 gene, which is one of the primary genetic factors associated with osteogenesis imperfecta (OI), a group of genetic disorders characterized by fragile bones that break easily. Osteogenesis imperfecta, also known as "brittle bone disease," can vary in severity from mild to severe and is caused by defects in the collagen protein, which is essential for bone strength and structure.
The test specifically targets the COL1A1 gene to identify mutations that may lead to the production of abnormal type I collagen, a key structural component of bone, skin, and other connective tissues. Identifying mutations in this gene can help in confirming a diagnosis of osteogenesis imperfecta, understanding its severity, and guiding treatment and management decisions.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis with a focus on accuracy and reliability. The cost of the COL1A1 gene osteogenesis imperfecta genetic test is 4400 AED. Given the complexity of genetic testing and the specialized nature of this test, it represents a crucial investment in understanding and managing osteogenesis imperfecta effectively. Patients and healthcare providers considering this test are encouraged to discuss its implications fully to ensure a comprehensive approach to treatment and care.
